Anna Bogacz

1.2k total citations
102 papers, 919 citations indexed

About

Anna Bogacz is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Anna Bogacz has authored 102 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 19 papers in Oncology and 17 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Anna Bogacz's work include Bone health and osteoporosis research (14 papers), Bone Metabolism and Diseases (13 papers) and Pregnancy and preeclampsia studies (10 papers). Anna Bogacz is often cited by papers focused on Bone health and osteoporosis research (14 papers), Bone Metabolism and Diseases (13 papers) and Pregnancy and preeclampsia studies (10 papers). Anna Bogacz collaborates with scholars based in Poland, United States and China. Anna Bogacz's co-authors include Joanna Bartkowiak-Wieczorek, Bogusław Czerny, Agnieszka Seremak‐Mrozikiewicz, Przemysław Ł. Mikołajczak, P.M. Mrozikiewicz, Marcin Ożarowski, Radosław Kujawski, Michał Szulc, Edmund Grześkowiak and T. Bobkiewicz‐Kozłowska and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Anna Bogacz

98 papers receiving 888 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Bogacz Poland 15 296 161 122 117 108 102 919
Sherine M. Rizk Egypt 20 399 1.3× 64 0.4× 90 0.7× 110 0.9× 70 0.6× 42 1.0k
Siu Wai Tsang Hong Kong 22 362 1.2× 79 0.5× 232 1.9× 123 1.1× 131 1.2× 40 1.2k
Wei Peng China 21 665 2.2× 105 0.7× 122 1.0× 145 1.2× 84 0.8× 61 1.3k
Weiying Guo China 18 565 1.9× 96 0.6× 60 0.5× 98 0.8× 71 0.7× 42 1.2k
Tawar Qaradakhi Australia 15 356 1.2× 58 0.4× 126 1.0× 62 0.5× 48 0.4× 23 1.1k
Hossam M.M. Arafa Egypt 19 257 0.9× 51 0.3× 92 0.8× 69 0.6× 99 0.9× 28 910
Eman T. Mehanna Egypt 18 235 0.8× 62 0.4× 88 0.7× 109 0.9× 57 0.5× 59 791
Martina Rudnicki Brazil 18 284 1.0× 91 0.6× 151 1.2× 88 0.8× 59 0.5× 34 1.1k
Cristina Nencini Italy 16 364 1.2× 67 0.4× 80 0.7× 303 2.6× 117 1.1× 36 1.3k
Saeed Changizi‐Ashtiyani Iran 19 203 0.7× 172 1.1× 120 1.0× 166 1.4× 158 1.5× 86 1.1k

Countries citing papers authored by Anna Bogacz

Since Specialization
Citations

This map shows the geographic impact of Anna Bogacz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Bogacz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Bogacz more than expected).

Fields of papers citing papers by Anna Bogacz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Bogacz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Bogacz. The network helps show where Anna Bogacz may publish in the future.

Co-authorship network of co-authors of Anna Bogacz

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Bogacz. A scholar is included among the top collaborators of Anna Bogacz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Bogacz. Anna Bogacz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bogacz, Anna, et al.. (2024). Modern immunotherapy using CAR-T cells in haemato-oncology and solid tumors. Acta Haematologica Polonica. 1 indexed citations
2.
3.
Bogacz, Anna, et al.. (2023). Osteoprotegerin Gene as a Biomarker in the Development of Osteoporosis in Postmenopausal Women. Biomedicines. 11(12). 3218–3218. 1 indexed citations
4.
5.
Gorący, Jarosław, Anna Bogacz, Małgorzata Łochyńska, et al.. (2021). The Analysis of NADPH Quinone Reductase 1 (NQO1) Polymorphism in Polish Patients with Colorectal Cancer. Biomolecules. 11(7). 1024–1024. 5 indexed citations
6.
Sieńko, Jerzy, et al.. (2020). COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients. SHILAP Revista de lepidopterología. 2 indexed citations
7.
Buchwald, Waldemar, Michał Szulc, Anna Piasecka, et al.. (2020). The Effect of Different Water Extracts from Platycodon grandiflorum on Selected Factors Associated with Pathogenesis of Chronic Bronchitis in Rats. Molecules. 25(21). 5020–5020. 13 indexed citations
8.
Górska, Aleksandra, et al.. (2020). Polymorphism analysis of the Gly972Arg IRS-1 and Gly1057Asp IRS-2 genes in obese pregnant women. Reproductive Biology. 20(3). 365–370. 3 indexed citations
9.
Bogacz, Anna, et al.. (2018). Expression profiling of genes modulated by rosmarinic acid (RA) in MCF-7 breast cancer cells. Ginekologia Polska. 89(10). 541–545. 13 indexed citations
10.
Wolski, Hubert, Krzysztof Drews, Anna Bogacz, et al.. (2016). The RANKL/RANK/OPG signal trail: significance of genetic polymorphisms in the etiology of postmenopausal osteoporosis. Ginekologia Polska. 87(5). 347–352. 20 indexed citations
11.
Boroń, Dariusz, et al.. (2015). Polymorphisms of OPG and their relation to the mineral density of bones in pre- and postmenopausal women. International Immunopharmacology. 28(1). 477–486. 8 indexed citations
12.
Bogacz, Anna, Daniel Kotrych, Hubert Wolski, et al.. (2015). The APOB gene polymorphism in the pathogenesis of gallstone disease in pre- and postmenopausal women. Menopausal Review. 1(1). 35–40. 2 indexed citations
13.
Gryszczyńska, Agnieszka, Mariola Dreger, Waldemar Buchwald, et al.. (2012). Proanthocyanidins in Rhodiola kirilowii and Rhodiola rosea callus tissues and transformed roots – determination with UPLC-MS/MS method. Herba Polonica. 58(4). 1 indexed citations
14.
Bogacz, Anna, Monika Karasiewicz, Radosław Kujawski, et al.. (2012). Molecular mechanisms of regulation of CYP enzymes of phase I metabolism of xenobiotics - synthetic drugs and herbal preparations. Herba Polonica. 58(3). 5 indexed citations
15.
Kujawski, Radosław, Joanna Bartkowiak-Wieczorek, Marcin Ożarowski, et al.. (2011). Current knowledge on phytochemical profile of Epilobium sp.raw materials and extracts. Potential benefits in nutrition and phytotherapy of age-related diseases. Herba Polonica. 57(4). 4 indexed citations
16.
Kujawski, Radosław, P.M. Mrozikiewicz, Przemysław Ł. Mikołajczak, et al.. (2010). Influence of Epilobium angustifolium and Serenoa repens extracts on cytochrome 2D2 and 3A1 expression level in rats.. Herba Polonica. 56(4). 39–51. 4 indexed citations
17.
Kujawski, Radosław, Anna Bogacz, Przemysław Ł. Mikołajczak, et al.. (2010). Medicinal plants from Epilobium genus - biological and pharmacological properties.. Herba Polonica. 56(1). 66–82. 2 indexed citations
18.
Kujawski, Radosław, Marcin Ożarowski, Joanna Bartkowiak-Wieczorek, et al.. (2009). Effect of Willow herb [Epilobium angustifolium L.] extract on gene expression of selected P450 cytochromes in rat liver - preliminary study. Herba Polonica. 55(4). 52–64. 2 indexed citations
19.
Seremak‐Mrozikiewicz, Agnieszka, Krzysztof Drews, Przemysław Ł. Mikołajczak, et al.. (2008). [The influence of interleukin-6 and tumor necrosis factor alpha gene polymorphisms on bone mineral density in postmenopausal women].. PubMed. 79(6). 426–31. 7 indexed citations
20.
Furmanowa, M., Mariola Dreger, A Mścisz, et al.. (2008). Rhodiola kirilowii - the present status and perspectives of medicinal use Part I. In vivo and in vitro cultivation as well as phytochemical investigations of extracts of roots and callus tissues. Herba Polonica. 54(4). 140–157. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sherine M. Rizk Breakdown of academic impact, for papers by Siu Wai Tsang Breakdown of academic impact, for papers by Wei Peng Breakdown of academic impact, for papers by Weiying Guo Breakdown of academic impact, for papers by Tawar Qaradakhi Breakdown of academic impact, for papers by Hossam M.M. Arafa Breakdown of academic impact, for papers by Eman T. Mehanna Breakdown of academic impact, for papers by Martina Rudnicki Breakdown of academic impact, for papers by Cristina Nencini Breakdown of academic impact, for papers by Saeed Changizi‐Ashtiyani
Rankless by CCL
2026